Biosig Total Assets vs Net Working Capital Analysis

BSGM Stock

USD 1.61 0.06 3.87%

Biosig Technologies financial indicator trend analysis is way more than just evaluating Biosig Technologies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biosig Technologies is a good investment. Please check the relationship between Biosig Technologies Total Assets and its Net Working Capital accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biosig Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

To learn how to invest in Biosig Stock, please use our How to Invest in Biosig Technologies guide.

Total Assets vs Net Working Capital

Total Assets vs Net Working Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biosig Technologies Total Assets account and Net Working Capital. At this time, the significance of the direction appears to have totally related.

The correlation between Biosig Technologies' Total Assets and Net Working Capital is 0.99. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Net Working Capital in the same time period over historical financial statements of Biosig Technologies, assuming nothing else is changed. The correlation between historical values of Biosig Technologies' Total Assets and Net Working Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Biosig Technologies are associated (or correlated) with its Net Working Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Working Capital has no effect on the direction of Total Assets i.e., Biosig Technologies' Total Assets and Net Working Capital go up and down completely randomly.

Correlation Coefficient

0.99

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Total Assets

Total assets refers to the total amount of Biosig Technologies assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Biosig Technologies books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Net Working Capital

Most indicators from Biosig Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biosig Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biosig Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

To learn how to invest in Biosig Stock, please use our How to Invest in Biosig Technologies guide.At this time, Biosig Technologies' Issuance Of Capital Stock is very stable compared to the past year. As of the 17th of May 2024, Sales General And Administrative To Revenue is likely to grow to 1,346, while Selling General Administrative is likely to drop about 19.1 M.

	2023	2024 (projected)
Extraordinary Items	2.9M	2.6M
Reconciled Depreciation	361K	232.6K

Extraordinary Items Reconciled Depreciation

Biosig Technologies fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Warrants	Accounts Payable	Other Assets	Retained Earnings Total Equity	Capital Surpluse
Total Assets		-0.08	0.24	0.33	0.99	0.46	-0.98	-0.38	0.99	0.42	0.05	0.99	0.5	-0.53	0.44	0.37	0.17	1.0	0.24	0.46	0.76	-0.54	-0.27	0.09	-0.63	0.51
Short Long Term Debt Total	-0.08		-0.55	-0.5	-0.01	0.0	0.17	0.0	-0.09	0.02	0.06	-0.09	0.07	-0.31	0.0	-0.49	0.0	-0.08	0.32	0.11	-0.08	-0.03	0.1	0.08	0.02	-0.03
Other Current Liab	0.24	-0.55		0.99	0.12	0.12	-0.29	-0.31	0.25	0.09	0.03	0.26	0.42	-0.03	0.31	0.96	0.22	0.24	0.08	0.1	0.35	-0.19	-0.26	-0.48	-0.3	0.33
Total Current Liabilities	0.33	-0.5	0.99		0.2	0.24	-0.35	-0.42	0.32	0.21	0.08	0.32	0.51	-0.14	0.41	0.99	0.32	0.32	0.11	0.16	0.47	-0.28	-0.35	-0.4	-0.42	0.44
Total Stockholder Equity	0.99	-0.01	0.12	0.2		0.43	-0.97	-0.32	0.98	0.39	0.03	0.98	0.44	-0.51	0.37	0.24	0.1	0.99	0.22	0.46	0.7	-0.51	-0.21	0.13	-0.58	0.44
Property Plant And Equipment Net	0.46	0.0	0.12	0.24	0.43		-0.31	-0.85	0.33	0.97	0.63	0.34	0.73	-0.6	0.84	0.38	0.84	0.37	0.26	0.67	0.75	-0.72	-0.58	0.41	-0.89	0.83
Net Debt	-0.98	0.17	-0.29	-0.35	-0.97	-0.31		0.26	-1.0	-0.27	0.06	-1.0	-0.42	0.42	-0.32	-0.37	-0.03	-0.99	-0.21	-0.37	-0.68	0.46	0.17	-0.03	0.52	-0.4
Retained Earnings	-0.38	0.0	-0.31	-0.42	-0.32	-0.85	0.26		-0.28	-0.81	-0.42	-0.28	-0.81	0.43	-1.0	-0.51	-0.95	-0.31	-0.41	-0.44	-0.84	0.84	0.53	-0.24	0.95	-0.99
Cash	0.99	-0.09	0.25	0.32	0.98	0.33	-1.0	-0.28		0.29	-0.05	1.0	0.42	-0.47	0.34	0.34	0.05	1.0	0.21	0.38	0.69	-0.46	-0.2	0.04	-0.53	0.41
Non Current Assets Total	0.42	0.02	0.09	0.21	0.39	0.97	-0.27	-0.81	0.29		0.78	0.29	0.69	-0.53	0.8	0.34	0.81	0.33	0.27	0.75	0.72	-0.71	-0.52	0.38	-0.86	0.79
Non Currrent Assets Other	0.05	0.06	0.03	0.08	0.03	0.63	0.06	-0.42	-0.05	0.78		-0.05	0.34	-0.26	0.39	0.18	0.46	-0.03	0.1	0.75	0.29	-0.32	-0.28	0.11	-0.44	0.36
Cash And Short Term Investments	0.99	-0.09	0.26	0.32	0.98	0.34	-1.0	-0.28	1.0	0.29	-0.05		0.43	-0.47	0.34	0.35	0.05	1.0	0.21	0.38	0.69	-0.47	-0.2	0.04	-0.54	0.42
Common Stock Total Equity	0.5	0.07	0.42	0.51	0.44	0.73	-0.42	-0.81	0.42	0.69	0.34	0.43		-0.37	0.81	0.59	0.67	0.45	0.72	0.66	0.67	-0.89	-0.14	0.16	-0.86	0.81
Common Stock Shares Outstanding	-0.53	-0.31	-0.03	-0.14	-0.51	-0.6	0.42	0.43	-0.47	-0.53	-0.26	-0.47	-0.37		-0.46	-0.23	-0.44	-0.49	-0.04	-0.38	-0.57	0.32	0.64	-0.23	0.51	-0.47
Other Stockholder Equity	0.44	0.0	0.31	0.41	0.37	0.84	-0.32	-1.0	0.34	0.8	0.39	0.34	0.81	-0.46		0.51	0.94	0.37	0.42	0.44	0.87	-0.86	-0.53	0.24	-0.96	1.0
Total Liab	0.37	-0.49	0.96	0.99	0.24	0.38	-0.37	-0.51	0.34	0.34	0.18	0.35	0.59	-0.23	0.51		0.42	0.34	0.14	0.27	0.54	-0.36	-0.41	-0.32	-0.52	0.53
Property Plant And Equipment Gross	0.17	0.0	0.22	0.32	0.1	0.84	-0.03	-0.95	0.05	0.81	0.46	0.05	0.67	-0.44	0.94	0.42		0.08	0.26	0.35	0.72	-0.7	-0.62	0.3	-0.84	0.91
Total Current Assets	1.0	-0.08	0.24	0.32	0.99	0.37	-0.99	-0.31	1.0	0.33	-0.03	1.0	0.45	-0.49	0.37	0.34	0.08		0.22	0.4	0.71	-0.49	-0.22	0.05	-0.56	0.44
Short Term Debt	0.24	0.32	0.08	0.11	0.22	0.26	-0.21	-0.41	0.21	0.27	0.1	0.21	0.72	-0.04	0.42	0.14	0.26	0.22		0.46	0.25	-0.72	0.44	0.26	-0.45	0.41
Common Stock	0.46	0.11	0.1	0.16	0.46	0.67	-0.37	-0.44	0.38	0.75	0.75	0.38	0.66	-0.38	0.44	0.27	0.35	0.4	0.46		0.39	-0.59	-0.05	0.07	-0.6	0.44
Net Tangible Assets	0.76	-0.08	0.35	0.47	0.7	0.75	-0.68	-0.84	0.69	0.72	0.29	0.69	0.67	-0.57	0.87	0.54	0.72	0.71	0.25	0.39		-0.74	-0.61	0.2	-0.92	0.91
Warrants	-0.54	-0.03	-0.19	-0.28	-0.51	-0.72	0.46	0.84	-0.46	-0.71	-0.32	-0.47	-0.89	0.32	-0.86	-0.36	-0.7	-0.49	-0.72	-0.59	-0.74		0.08	-0.39	0.89	-0.86
Accounts Payable	-0.27	0.1	-0.26	-0.35	-0.21	-0.58	0.17	0.53	-0.2	-0.52	-0.28	-0.2	-0.14	0.64	-0.53	-0.41	-0.62	-0.22	0.44	-0.05	-0.61	0.08		0.02	0.48	-0.53
Other Assets	0.09	0.08	-0.48	-0.4	0.13	0.41	-0.03	-0.24	0.04	0.38	0.11	0.04	0.16	-0.23	0.24	-0.32	0.3	0.05	0.26	0.07	0.2	-0.39	0.02		-0.25	0.25
Retained Earnings Total Equity	-0.63	0.02	-0.3	-0.42	-0.58	-0.89	0.52	0.95	-0.53	-0.86	-0.44	-0.54	-0.86	0.51	-0.96	-0.52	-0.84	-0.56	-0.45	-0.6	-0.92	0.89	0.48	-0.25		-0.97
Capital Surpluse	0.51	-0.03	0.33	0.44	0.44	0.83	-0.4	-0.99	0.41	0.79	0.36	0.42	0.81	-0.47	1.0	0.53	0.91	0.44	0.41	0.44	0.91	-0.86	-0.53	0.25	-0.97

Click cells to compare fundamentals

Biosig Technologies Account Relationship Matchups

Biosig Technologies fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	14.2M	30.4M	15.5M	4.1M	1.8M	1.7M
Other Current Liab	1.6M	4.8M	2.3M	2.9M	4.2M	3.0M
Total Current Liabilities	2.0M	5.1M	2.6M	3.3M	4.6M	3.2M
Total Stockholder Equity	11.4M	24.5M	12.3M	418K	(2.9M)	(2.8M)
Property Plant And Equipment Net	894.7K	595.0K	1.3M	1.5M	938K	531.7K
Net Debt	(11.4M)	(28.0M)	(11.0M)	408K	262K	275.1K
Retained Earnings	(104.8M)	(157.0M)	(188.9M)	(216.0M)	(245.0M)	(232.8M)
Cash	12.1M	28.3M	11.7M	357K	190K	180.5K
Non Current Assets Total	1.4M	1.0M	1.6M	3.0M	1.3M	890.5K
Non Currrent Assets Other	129.2K	107K	42K	1.2M	43K	40.9K
Cash And Short Term Investments	12.1M	28.3M	11.7M	458K	293K	278.4K
Common Stock Total Equity	29.3K	16.9K	23.3K	31K	35.7K	21.9K
Common Stock Shares Outstanding	2.1M	2.8M	3.4M	4.3M	7.4M	5.1M
Liabilities And Stockholders Equity	14.2M	30.4M	15.5M	4.1M	1.8M	1.7M
Other Stockholder Equity	115.9M	181.3M	201.1M	216.2M	242.1M	254.2M
Total Liab	2.3M	5.1M	3.0M	3.7M	4.7M	3.4M
Property Plant And Equipment Gross	894.7K	595.0K	1.8M	2.4M	2.5M	2.6M
Total Current Assets	12.8M	29.3M	13.9M	1.1M	528K	501.6K
Common Stock	23.3K	31K	36K	55K	9K	8.6K
Net Tangible Assets	3.1M	10.8M	24.0M	11.9M	13.7M	14.4M
Warrants	985K	475K	215K	105K	94.5K	89.8K
Accounts Payable	346.2K	30K	1K	2.9K	2.6K	2.4K
Other Assets	54.2K	129K	(44.0)	42K	48.3K	44.3K
Retained Earnings Total Equity	(56.5M)	(70.7M)	(104.8M)	(157.0M)	(141.3M)	(134.2M)
Capital Surpluse	53.2M	74.0M	115.9M	181.3M	208.5M	219.0M
Other Current Assets	141.2K	301K	354K	325.0	314K	181.2K
Property Plant Equipment	44.3K	894K	595K	1.3M	1.4M	1.5M
Non Current Liabilities Total	311.1K	1K	378K	452K	103K	175.3K
Net Invested Capital	11.1M	24.4M	12.2M	313K	(3.0M)	(2.9M)
Net Working Capital	10.8M	24.2M	11.3M	(2.1M)	(4.1M)	(3.9M)
Capital Stock	238.3K	136K	141K	160K	114K	170.8K
Intangible Assets	365.7K	347K	327K	308K	289K	254.2K

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Biosig Technologies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether Biosig Technologies is a strong investment it is important to analyze Biosig Technologies' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biosig Technologies' future performance. For an informed investment choice regarding Biosig Stock, refer to the following important reports:

How To Invest In Biosig

Details

Is Biosig Stock a good investment?

Details

What is Biosig Technologies' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biosig Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

To learn how to invest in Biosig Stock, please use our How to Invest in Biosig Technologies guide.

Note that the Biosig Technologies information on this page should be used as a complementary analysis to other Biosig Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Biosig Stock analysis

When running Biosig Technologies' price analysis, check to measure Biosig Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosig Technologies is operating at the current time. Most of Biosig Technologies' value examination focuses on studying past and present price action to predict the probability of Biosig Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosig Technologies' price. Additionally, you may evaluate how the addition of Biosig Technologies to your portfolios can decrease your overall portfolio volatility.

	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Stocks Directory Find actively traded stocks across global markets
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Global Correlations Find global opportunities by holding instruments from different markets
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum

Is Biosig Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biosig Technologies. If investors know Biosig will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biosig Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.95)

Revenue Per Share

0.002

Quarterly Revenue Growth

(0.91)

Return On Assets

(6.03)

Return On Equity

(59.77)

The market value of Biosig Technologies is measured differently than its book value, which is the value of Biosig that is recorded on the company's balance sheet. Investors also form their own opinion of Biosig Technologies' value that differs from its market value or its book value, called intrinsic value, which is Biosig Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biosig Technologies' market value can be influenced by many factors that don't directly affect Biosig Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biosig Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biosig Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biosig Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biosig Total Assets vs Net Working Capital Analysis

Total Assets vs Net Working Capital

Total Assets vs Net Working Capital Correlation Analysis

Correlation Coefficient

Total Assets

Net Working Capital

Biosig Technologies fundamental ratios Correlations

Biosig Technologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biosig Technologies fundamental ratios Accounts

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Biosig Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Capital Surpluse	+ 1.0	Other Stockholder Equity
Total Stockholder Equity	+ 0.99	Total Assets

Other Stockholder Equity	- 1.0	Retained Earnings
Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Capital Surpluse	- 0.99	Retained Earnings
Total Current Assets	- 0.99	Net Debt
Net Debt	- 0.98	Total Assets